Agreement will expand access to key drug for resistant TB (By: Chris Dall, MA)
An agreement between the Stop TB Partnership and pharmaceutical giant Johnson & Johnson (J&J) will expand access to a key component of the shorter drug regimen for multidrug-resistant tuberculosis (MDR-TB). Under the agreement, which was…








